Masked hypertension incidence and risk factors in a prospective cohort study.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 27 9 2018
medline: 1 9 2020
entrez: 27 9 2018
Statut: ppublish

Résumé

Masked hypertension may affect up to 30% of the general population and is associated with a high cardiovascular disease risk. No previous study has examined the incidence of masked hypertension and its risk factors. The study aim was to determine the incidence of masked hypertension and to examine its related risk factors. This is a cohort study including 1836 initially normotensive participants followed up on average for 2.9 years. Blood pressure was measured using Spacelabs 90207. Manual blood pressure was defined as the mean of the first three readings taken at rest. Ambulatory blood pressure was defined as the mean of the next readings recorded every 15 minutes during daytime working hours. Masked hypertension incidence at follow-up was defined as manual blood pressure less than 140 and less than 90 mmHg and ambulatory blood pressure at least 135 or at least 85 mmHg. Generalised estimating equations were used. The cumulative incidence of masked hypertension was 10.3% and was associated with male gender (relative risk (RR) 1.51, 95% confidence interval (CI) 1.18-1.94), older age (RR The present study is the first to identify risk factors for the incidence of masked hypertension. Current guidelines for hypertension detection recommend ambulatory blood pressure in patients with an elevated blood pressure reading at the clinic. As it is impractical to measure ambulatory blood pressure in all normotensive patients, factors identified in the present study should be considered for the screening of at-risk individuals and for primary prevention of masked hypertension.

Identifiants

pubmed: 30256672
doi: 10.1177/2047487318802692
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-237

Subventions

Organisme : CIHR
ID : 57750
Pays : Canada

Auteurs

Xavier Trudel (X)

1 Social and Preventive Medicine Department, Laval University, Canada.
2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.

Chantal Brisson (C)

1 Social and Preventive Medicine Department, Laval University, Canada.
2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.

Mahée Gilbert-Ouimet (M)

3 Institute for Work and Health, Canada.

Caroline S Duchaine (CS)

2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.

Violaine Dalens (V)

2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.

Denis Talbot (D)

1 Social and Preventive Medicine Department, Laval University, Canada.
2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.

Alain Milot (A)

2 Axe santé des populations et pratiques optimales en santé, Laval University, Canada.
4 Department of Medicine, Laval University, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH